Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Scibase AB

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Scibase AB

Regulatory records
2
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 2 FDA records to the applicant name Scibase AB. 1 entry is a PMA supplement. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 15, 2025 to Feb 26, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code ONV appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P150046, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: Kammakargatan 22, Stockholm, SE-1140. Recorded on P150046/S005, decision dated Feb 26, 2026.

Changes described in PMA records

P150046/S005: Nevisense

FDA’s recorded scope: Approval for replacing the user manual text, Nevisense may only be used by dermatologists who have successfully completed the Nevisense training, with the following: Only dermatologists, who have completed Nevisense training, may initiate a Nevisense examination and utilize the Nevisense results in conjunction with other clinical parameters toobtain additional information prior to decision to biopsy. Nevisense may only be operated by healthcare professionals who have successfully completed the Nevisense training.

Feb 26, 2026 · Real-Time Process

P150046/S006: Nevisense

FDA’s recorded scope: approval for an automated electrical test station and data acquisition process for quality testing of finished disposable Nevisense electrodes, while retaining the existing manual electrical test station and process

Dec 15, 2025 · 30-Day Notice

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
NevisenseP150046/S005
Scibase ABPMA supplementFeb 26, 2026FDA
NevisenseP150046/S006
Scibase ABPMA supplementDec 15, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.